Warrensville Heights, OH – According to filings with the U.S. Securities and Exchange Commission, Flow Pharma is raising $10,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Reid Rubsamen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Flow Pharma
Flow Pharma engineers and manufactures revolutionary medicines. Our unique patented delivery systems and biotechnology are ideally suited for curative intervention in COVID-19, Ebola, and treatment-resistant cancers.

To learn more about Flow Pharma, visit http://www.flowpharma.com/

Contact:
Reid Rubsamen, Chief Executive Officer
216-350-8361
https://www.linkedin.com/in/reid-rubsamen-627702243/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved